David M. Berman, HEAD OF R&D at Immunocore Holdings plc (IMCR), sold 149,850 shares at $40.09 ($6.0M) on 2025-11-28, disclosed to the SEC on 2025-12-01.
Scheduled sale ($6.0M) by HEAD OF R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.12 | 69,404 | $2.8M | 46.3% |
| 2 | $40.12 | 69,404 | $2.8M | 46.3% |
| 3 | $40.09 | 5,521 | $221K | 3.7% |
| 4 | $40.09 | 5,521 | $221K | 3.7% |
| Total | $40.12 avg | 149,850 | $6.0M | 100% |
| Filing → |
| IMCR | SELL | 2025-11-26 | $1.4M | — | Filing → |
| IMCR | SELL | 2025-10-02 | $4.4M | — | Filing → |
| IMCR | SELL | 2025-09-16 | $1.6M | — | Filing → |